Strongbridge Biopharma plc announced that Garheng Kong, founder and managing partner of HealthQuest Capital, has been appointed to the company's board of directors, effective immediately. The company also announced that Joseph M. Mahady, who has served as a director, has elected to step down from the Strongbridge Biopharma board of directors. Dr. Kong has nearly 20 years of clinical and technical experience in creating and building high-growth and innovation-based healthcare businesses.

He currently serves on the Boards of Alimera Sciences, Castle Biosciences, Cempra, Duke University Medical Center, First Aid Shot Therapy, Histogenics, Laboratory Corporation of America, Trice Medical and VirMedica. He previously served on the Boards of SEBIO, the North Carolina Biotechnology Center and numerous industry groups.